Who has invested in OncoImmune?

HM Capital, 3E Bioventures Capital, Kaitai Capital, GBA Fund, GF Xinde are named among the investors backing OncoImmune.

OncoImmune Funding: $56M Raised, Series B (2020)

OncoImmune funding overview

OncoImmune is based in Rockville. OncoImmune has raised $56M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in September 2020. The round record for OncoImmune runs through 2020; nothing later has been disclosed. Investors on record include HM Capital, 3E Bioventures Capital, Kaitai Capital, GBA Fund, GF Xinde. 5 distinct backers are named across the disclosed rounds.

OncoImmune at a glance

Total raised: $56M
Latest round: Series B
Latest round date: September 2020
Headquarters: Rockville
Notable investors: HM Capital, 3E Bioventures Capital, Kaitai Capital, GBA Fund, GF Xinde

Frequently asked about OncoImmune funding

How much has OncoImmune raised?: OncoImmune has raised $56M in total disclosed funding across the rounds on record.
Who has invested in OncoImmune?: HM Capital, 3E Bioventures Capital, Kaitai Capital, GBA Fund, GF Xinde are named among the investors backing OncoImmune.
What was the latest OncoImmune funding round?: The most recent disclosed round is a Series B, announced in September 2020.
Where is OncoImmune based?: OncoImmune is based in Rockville.
When did OncoImmune last raise?: The last disclosed OncoImmune round closed in September 2020 at Series B.

Every OncoImmune figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Rockville at a similar stage.

OncoImmune Funding: $56M Raised, Series B (2020)

OncoImmune funding overview

OncoImmune at a glance

Frequently asked about OncoImmune funding

Companies related to OncoImmune (14)

Browse related funding lists (5)